Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
84,726
-
Share change
-
+84,726
-
Total reported value
-
$305,010
-
Price per share
-
$3.60
-
Number of holders
-
15
-
Value change
-
+$305,010
-
Number of buys
-
15
Institutional Holders of Cardio Diagnostics Holdings, Inc. - COM NEW (CDIO) as of Q2 2025
As of 30 Jun 2025,
Cardio Diagnostics Holdings, Inc. - COM NEW (CDIO) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,726 shares.
The largest 10 holders included
BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, Royal Bank of Canada, PNC Financial Services Group, Inc., UBS Group AG, OSAIC HOLDINGS, INC., WOLVERINE ASSET MANAGEMENT LLC, and Tower Research Capital LLC (TRC).
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.